Attention-deficit hyperactivity disorder and the stress response

被引:103
|
作者
King, JA [1 ]
Barkley, RA [1 ]
Barrett, S [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA
关键词
attention-deficit hyperactivity disorder; stress; hypothalamic-pituitary-adrenal axis; cortisol; development;
D O I
10.1016/S0006-3223(97)00507-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder whose three main symptoms are impulsiveness, inattention, and hyperactivity. Researchers have proposed that the central deficit in ADHD is one of poor response inhibition. The present studies were designed to look at the functioning of the hypothalamic-pituitary-adrenal (HPA) axis in response to mental stress in aggressive ADHD subjects participating in a longitudinal study of various psychosocial treatments. Methods: Pretest and posttest morning salivary samples for cortisol determination were collected from subjects given a battery of tests. Results: The study shows that ADHD subjects who maintained their diagnosis otter the first year of the study had a blunted response to the stressor in comparison to those ADHD subjects who no longer retained the disorder 1 year later. Conclusions: The data suggest that an impaired response to stress may be a marker for the more developmentally persistent form of the disorder. Biol Psychiatry 1998;44: 72-74 (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 50 条
  • [21] Neglect in attention-deficit hyperactivity disorder
    Streeck-Fischer, A
    PSYCHOTHERAPEUT, 2006, 51 (02): : 80 - 90
  • [22] Inattentiveness in attention-deficit/hyperactivity disorder
    Sroubek, Ariane
    Kelly, Mary
    Li, Xiaobo
    NEUROSCIENCE BULLETIN, 2013, 29 (01) : 103 - 110
  • [23] 6 Developmental comorbidity in attention-deficit/hyperactivity disorder
    Taurines, Regina
    Schmitt, Jochen
    Renner, Tobias
    Conner, Alex Curtis
    Warnke, Andreas
    Romanos, Marcel
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2010, 2 (04) : 267 - 289
  • [24] Measure of Caregiver Attention-Deficit/Hyperactivity Disorder Knowledge Is Responsive to Decision Aid on Treatment for Attention-Deficit/Hyperactivity Disorder
    Valentine, Kathrene Diane
    Lipstein, Ellen A.
    Vo, Ha
    Cosenza, Carol
    Barry, Michael J.
    Mancini, Brittney
    Brinkman, William B.
    Sepucha, Karen
    ACADEMIC PEDIATRICS, 2024, 24 (03) : 417 - 423
  • [25] Comorbid attention-deficit hyperactivity disorder and bipolar disorder
    Parker, Gordon
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (06) : 789 - 792
  • [27] Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers
    Vogel, S. W. N.
    Bijlenga, D.
    Verduijn, J.
    Bron, T. I.
    Beekman, A. T. F.
    Kooij, J. J. S.
    Penninx, B. W. J. H.
    PSYCHONEUROENDOCRINOLOGY, 2017, 79 : 31 - 39
  • [28] Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder
    Cowles, Brian J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) : 669 - 676
  • [29] Cytogenetic abnormalities in attention-deficit/hyperactivity disorder
    Bastain, TM
    Lewczyk, CM
    Sharp, WS
    James, RS
    Long, RT
    Eagen, PB
    Ebens, CL
    Meck, JM
    Chan, WY
    Sidransky, E
    Rapoport, JL
    Castellanos, EX
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (07) : 806 - 810
  • [30] Diagnosis and treatment of attention-deficit/hyperactivity disorder
    Cipkala-Gaffin, JA
    PERSPECTIVES IN PSYCHIATRIC CARE, 1998, 34 (04) : 18 - 25